U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H23BrFN7O3
Molecular Weight 580.408
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Danicopan

SMILES

CC(=O)C1=NN(CC(=O)N2C[C@H](F)C[C@H]2C(=O)NC3=CC=CC(Br)=N3)C4=C1C=C(C=C4)C5=CN=C(C)N=C5

InChI

InChIKey=PIBARDGJJAGJAJ-NQIIRXRSSA-N
InChI=1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1

HIDE SMILES / InChI

Molecular Formula C26H23BrFN7O3
Molecular Weight 580.408
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
349 ng/mL
100 mg 3 times / day multiple, oral
dose: 100 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
DANICOPAN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
465 ng/mL
150 mg 3 times / day multiple, oral
dose: 150 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
DANICOPAN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
543 ng/mL
175 mg 3 times / day multiple, oral
dose: 175 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
DANICOPAN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1476 ng × h/mL
100 mg 3 times / day multiple, oral
dose: 100 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
DANICOPAN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
2019 ng × h/mL
150 mg 3 times / day multiple, oral
dose: 150 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
DANICOPAN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
2231 ng × h/mL
175 mg 3 times / day multiple, oral
dose: 175 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
DANICOPAN plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
Substance Class Chemical
Created
by admin
on Tue Apr 01 21:23:19 GMT 2025
Edited
by admin
on Tue Apr 01 21:23:19 GMT 2025
Record UNII
JM8C1SFX0U
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Danicopan
USAN   INN  
Official Name English
ACH-4471
Preferred Name English
DANICOPAN [JAN]
Common Name English
(2S,4R)-1-(2-(3-ACETYL-5-(2-METHYLPYRIMIDIN-5-YL)-1H-INDAZOL-1-YL)ACETYL)-N-(6-BROMOPYRIDIN-2-YL)-4-FLUOROPYRROLIDINE-2-CARBOXAMIDE
Systematic Name English
danicopan [INN]
Common Name English
ACH-0144471
Code English
(2S,4R)-1-{[3-Acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl]acetyl}-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide
Systematic Name English
DANICOPAN [USAN]
Common Name English
Danicopan [WHO-DD]
Common Name English
VOYDEYA
Brand Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 512715
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
EU-Orphan Drug EU/3/18/1989
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
FDA ORPHAN DRUG 617117
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
Code System Code Type Description
INN
10610
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
PRIMARY
NCI_THESAURUS
C148181
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
PRIMARY
SMS_ID
100000175510
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
PRIMARY
FDA UNII
JM8C1SFX0U
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
PRIMARY
DAILYMED
JM8C1SFX0U
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
PRIMARY
CAS
1903768-17-1
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
PRIMARY
PUBCHEM
118323590
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
PRIMARY
DRUG BANK
DB15401
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
PRIMARY
USAN
GH-91
Created by admin on Tue Apr 01 21:23:19 GMT 2025 , Edited by admin on Tue Apr 01 21:23:19 GMT 2025
PRIMARY
Related Record Type Details
BINDER->LIGAND
BINDING
OFF-TARGET->INHIBITOR
IC50 values for the human melatonin receptor (in vitro) are notably lower (2-fold to 11-fold) than the danicopan concentration expected to be achieved at the MRHD it.
IC50
TRANSPORTER -> SUBSTRATE
OFF-TARGET->INHIBITOR
Inhibition of the FXR by danicopan has the potential to promote cholestasis.
Related Record Type Details
METABOLITE INACTIVE -> PARENT
PLASMA
METABOLITE INACTIVE -> PARENT
MAJOR
PLASMA
METABOLITE INACTIVE -> PARENT
METABOLITE INACTIVE -> PARENT
METABOLITE -> PARENT
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
PERMEABILITY PHARMACOKINETIC